core-set of 17 arteries and respectively represent the sum of stenosis and dilation scores in individual arteries 1 . Objectives: To use ASS, ADS and the stenosis and dilation scores of individual arteries to describe a cohort of LVV patients and identify heterogeneity between patients. Methods: The ASS, ADS and individual artery scores have been derived from 110 LVV (81 TA, 29 GCA) patients. Model-based clustering optimising the Bayesian Information Criterion and principal component analysis were performed. Results: Arterial involvement was shown to be differed in GCA and TA: TA has higher ASS than GCA (median, IQR: 20,(11)(12)(13)(14)(15)(16)(17)(18)(19)(20)(21)(22)(23)(24)(25)(26)(27)(28)(29)(0)(1)(2)(3)(4)(5)(6)(7)(8)(9)(10)(11) p<0.001) and lower ADS (0, 0-5 Vs 6, 0-13; p=0.019). The scatterplot of ASS and ADS revealed incomplete overlap of arterial involvement in GCA and TA. No differences were seen in TA with disease onset before or after 40 yrs. Age at onset, ASS and ADS did not correlate in TA, suggesting stenotic and aneurysmal arterial remodelling are independent. In GCA, ASS and ADS were negatively correlated (ρ=-0.401; p=0.031) and ADS correlated with age at onset (ρ=0.383; p=0.040), suggesting the existence of a biologic "switch" between arterial stenosis and dilation, regulated by age at onset. We accounted for geographical distribution of lesions by evaluating the scores of individual arteries with correspondence analysis. Arterial involvement was symmetric with tripolar segregation: stenosis in the supra-aortic branches, stenosis in the aorto-abdominal district and arterial dilation (Fig 1A) . When patients exhibited the first two components, three different clusters were recognised ( Fig  1B) , with different ASS, ADS and damage as assessed by the TA damage score (p<0.001 for all tests). 27/29 (93%) of GCA patients were included in cluster 1 and 3, while 77/81 (95%) of TA clustered in 2 and 3. Of interest, density graphs showed (i) a different distribution of arterial involvement in GCA and TA ( Fig  1C-D) , and (ii) potential for identification of novel disease subsets (2 in GCA and 3 in TA). A comparable distribution was seen in TA with onset before or after 40 yrs ( Fig 1E) . Lastly, when patients with disease onset after 50 yrs (11 TA, 28 GCA) were studied, a trimodal distribution was observed, suggesting discrete phenotypes of arterial involvement exist, rather than a continuum (Fig 1F) .
Conclusions:
Arterial involvement differs in TA and GCA, although some overlap exists. Elderly TA is similar to juvenile TA, while a potential biologic "switch", yet to be identified, regulating the final outcome of arterial remodelling and influenced by ageing, is present in GCA. Three main patterns of arterial involvement appear to exist. LVVs represent the composition of different discrete subsets rather than a phenotypic continuum. ANCA were positive in all cases (15 C-ANCA-PR3, 5 P-ANCA-MPO). Headache was the main neurological symptom (60%) followed by sensory (45%) and motor impairment (35%). MRI and/or angio-CT scan were performed in all cases. Cerebral ischaemic lesions were observed in 10 patients, and granulomatous lesions in 9, including pachymeningitis (n=6), spinal cord pachymeningitis (n=2) and isolated granulomatous lesions (n=1). Lumbar puncture was performed in 8 (40%) patients and revealed CSF abnormalities in 70. Diagnosis was confirmed by meningeal biopsy (n=2), ENT biopsies (n=5) and renal biopsy (n=2) in patients with CNS granulomatous lesions, and by renal, pulmonary or peripheral nerve biopsy in patients with CNS ischemic lesions. Headache was predominant in patients with granulomatous lesions, while sensory and motor impairment were predominant in patients with ischemic lesions. Mean BVAS at disease onset was 29.2±9.7, significantly higher than in GPA total cohort (18.2±9.2). Renal involvement was more common in patients with ischaemic lesions than in those with granulomatous (80% vs. 40%, p<0.001), and ENT involvement in patients with granulomatous forms (70% vs. 50%, p<0.005). Most patients (70%) received oral CF for induction therapy. Two patients received rituximab. For maintenance therapy, 25% of patients received AZA, 20% MMF and the remaining CF. 70% of patients received TM-SX. During follow-up, 58.8% and 40% of patients developed bacterial and opportunistic infections, respectively. Infections were related to oral CF therapy (p=0.029). Long-term neurological sequelae were noted in patients with ischaemic lesions (40%) and spinal cord pachymeningitis (100%) Conclusions: Patients with GPA and CNS involvement have more severe disease at presentation and more treatment-related side effects than patients without CNS involvement. Long-term neurological sequelae are more frequent in patients with ischaemic lesions and spinal cord pachymeningitis Disclosure of Interest: None declared DOI: 10.1136/annrheumdis-2017-eular.2520
